Clinical Trials Logo
  1. Home
  2. Chronic Obstructive Lung Disease
  3. NCT00506701

Effect of Tadalafil in Chronic Obstructive Lung Disease Patients Suffering From Secondary Pulmonary Hypertension

Chronic Obstructive Lung Disease Clinical Trial

Official title:
Pilot Study to Investigate the Effect of Tadalafil on Secondary Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease

Clinical Trial Summary

Tadalafil may lower the pulmonary artery pressure in patients with Chronic Obstructive Lung Disease and secondary pulmonary hypertension and thereby improve patients quality of life.

Clinical Trial Description

Twenty outpatients with Chronic Obstructive Lung Disease (COPD) and secondary pulmonary hypertension are treated in a cross-over design with Tadalafil or placebo for 4 weeks. Primary effect parameter is 6 min. walking test. ;

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00506701
Study type Interventional
Source Herlev Hospital
Contact
Status Withdrawn
Phase N/A
Start date February 2008
Completion date February 2010
View Details
See also
  Status Clinical Trial Phase
Completed NCT01362855 - Advance Care Planning Evaluation in Hospitalized Elderly Patients
Withdrawn NCT01416701 - Vitamin D and Chronic Obstructive Lung Disease Phase 4
Completed NCT00202150 - Primary Care Management/Action Plans for Advanced Chronic Diseases Phase 2/Phase 3
Recruiting NCT05227547 - Mapping and Characterization of Alveolar Cells During Smoking and Chronic Obstructive Disease N/A
Withdrawn NCT02273349 - Lung Volume Reduction Coils for Emphysema in Alpha-1 Antitrypsin Deficiency N/A
Completed NCT00018408 - Genetic Mechanisms of Chronic Obstructive Pulmonary Disease (COPD) N/A
Completed NCT02987439 - COPD-EXA-REHAB. Early Pulmonary Rehabilitation of Patients With Acute Exacerbation of COPD N/A
Completed NCT01950936 - Procalcitonin To Reduce Antibiotics in Chronic Obstructive Lung Disease (ProToCOLD) Phase 2/Phase 3
Completed NCT01404000 - Treatment of Chronic Obstructive Pulmonary Disease (COPD) With Iodinated Activated Charcoal Phase 2
Terminated NCT03811158 - The Edi Level and Cardiopulmonary Function Between HHHFNC and Unheated Humidified High-Flow Oxygen Mask in COPD N/A
Recruiting NCT01631162 - The Identification of Different Lung Diseases by Analysis of Volatile Organic Compounds in Breath Samples N/A
Completed NCT01596023 - Evaluation of Breathe NIOV System on Work of Breathing in Chronic Obstructive Lung Disease Patients N/A
Completed NCT01347931 - In-home Evaluation of a Noninvasive Open Ventilation System in Patients With Severe Respiratory Insufficiency N/A
Terminated NCT01712854 - Effects of Symbicort on the Ventilatory Kinematics Phase 4
Completed NCT02462343 - Comparison of the Two and Six- Minute Walk Tests in Evaluating Oxygen Desaturation in Patients With Severe COPD N/A
Recruiting NCT06090149 - Telemedical Assistance in Automatic Titration of Oxygen for Intensive Care Patients N/A
Recruiting NCT02778802 - Pulmonary Hemodynamics in Patients With Severe Emphysema Pre and Post BLVR N/A
Enrolling by invitation NCT02278107 - Evaluation of a Lightweight Nasal Interface and Ventilator in Patients With Respiratory Disease N/A
Completed NCT01614951 - The Pulmonary Protection Trial Phase 4
Completed NCT01787097 - Effect of Symbicort ® on GR in Sputum in COPD Phase 4